Vivani Medical, Inc.

VANI Nasdaq SEC CIK 1266806
Follow Vivani Medical Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$7.3M −11% vs same quarter last year
EPS, diluted −$0.08 +27.3% vs same quarter last year
Operating cash flow −$6.4M −0.6% vs same quarter last year
Operating income −$7.5M −12% vs same quarter last year
Revenue by quarter
$0
$0
$0
Q4 24 Q1 25 Q2 25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income14 fiscal years
  • Revenue
  • Net income
−$40M−$20M$0$20MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$0-
FY24$0-
FY23--
FY22-−$13.9M
FY21-−$12.8M
FY20-−$14.9M
FY19$3.4M−$33.6M
FY18$6.9M−$35.1M
FY17$8M−$28.5M
FY16$4M−$33.2M
FY15$8.9M−$20M
FY14$3.4M−$35.2M
FY13$1.6M−$23M
FY12--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−1500%−1000%−500%0%500%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25---
FY24---
FY23---
FY22---
FY21---
FY20---
FY1936.3%−1004.9%−994.1%
FY1829.1%−509.9%−508.6%
FY1735.7%−359.2%−358.1%
FY16−152.3%−830.2%−829.5%
FY1541.1%−225.2%−224.9%
FY14−4.7%−624.5%−1035.3%
FY13−259.7%−1150%−1467.7%
FY12---
Free cash flowOperating cash flow minus capital expenditure
−$30M−$20M−$10M$0FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$25.5M
FY24−$21.3M
FY23−$24.6M
FY22−$19.1M
FY21−$11.5M
FY20−$17.2M
FY19−$28.1M
FY18−$30M
FY17−$24.2M
FY16−$25.6M
FY15−$21.3M
FY14−$17.7M
FY13−$17.7M
FY12-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Vivani Medical
  • Healthcare median
−1500%−1000%−500%0%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearVivani MedicalHealthcare median
FY25-−30.6%
FY24-−47%
FY23-−58%
FY22-−80.4%
FY21-−71.8%
FY20-−62.2%
FY19−994.1%−46.2%
FY18−508.6%−49.6%
FY17−358.1%−45.9%
FY16−829.5%−36%
FY15−224.9%−37.8%
FY14−1035.3%−35.5%
FY13−1467.7%−37.1%
FY12-−29.1%